The role of the opioid system in alcohol dependence
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The role of the brain opioid system in alcohol dependence has been the subject of much research for over 25 years. This review explores the evidence: firstly describing the opioid receptors in terms of their individual subtypes, neuroanatomy, neurophysiology and ligands; secondly, summarising emerging data from specific neurochemical, behavioural and neuroimaging studies, explaining the characteristics of addiction with a focus on alcohol dependence and connecting the opioid system with alcohol dependence; and finally reviewing the known literature regarding opioid antagonists in clinical use for alcohol dependence. Further interrogation of how modulation of the opioid system, via use of MOP (mu), DOP (delta) and KOP (kappa) agents, restores the balance of a dysregulated system in alcohol dependence should increase our insight into this disease process and therefore guide better methods for understanding and treating alcohol dependence in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
Endogenous opioid peptides: multiple agonists and receptors
Lord, J. A. H., Waterfield, A. A., Hughes, J., & Kosterlitz, H. W. (1977) · Nature · doi:10.1038/267495a0 · Cited by 2,485 · cited 2×
“Cleavage of proenkephalin yields the production of met- and leu-enkephalin, both of which exhibit a high affinity for the DOP, and an approximately 10-fold lower affinity for the MOP, with negligible affinity for the KOP (Lord et al., 1977).”
BackgroundNaltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Reward Processing by the Opioid System in the Brain
Le Merrer, J., Becker, J. A. J., Befort, K., & Kieffer, B. L. (2009) · Physiological Reviews · doi:10.1152/physrev.00005.2009 · Cited by 1,013
Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916
Kendler, K. S., Jacobson, K. C., Prescott, C. A., & Neale, M. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.687 · Cited by 693 · cited 1×
“genetic, environmental) are critical for the sensitivity of response to the first acute alcohol consumption event (Bierut, 2011; Kendler et al., 2003; Nestler, 2000).”
BackgroundRates and predictors of relapse after natural and treated remission from alcohol use disorders
Moos, R. H., & Moos, B. S. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01310.x · Cited by 601
A key role for corticotropin-releasing factor in alcohol dependence
Heilig, M., & Koob, G. F. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.006 · Cited by 503 · cited 2×
“It has been speculated that rewardcraving may result from alterations of the dopaminergic and opioidergic, specifically the beta-endorphin, systems whereas relief-craving may result from alterations in the GABAergic and glutaminergic systems and possibly the dynorphin systems (Wee and Koob, 2010) and CRF pathways (Hei…”
BackgroundAlteration of ethanol self-administration by naltrexone
Altshuler, H. L., Phillips, P. E., & Feinhandler, D. A. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90257-x · Cited by 397
Research works printed but not linked: 182
- 10.1097/01.ALC.0000158939.25531.EE · DOI · Paper page
- 10.1111/j.1360-0443.1987.tb01429.x · doi:10.1111/j.1360-0443.1987.tb01429.x
- Anton RF, 1999, Am J Psychiat, 156, 1758, 10.1176/ajp.156.11.1758 · DOI · Paper page
- 10.1176/appi.ajp.2011.10101436 · DOI · Paper page
- 10.1007/BF00549595 · DOI
- 10.1038/sj.npp.1300811 · DOI
- 10.1111/j.1369-1600.2011.00366.x · DOI · Paper page
- 10.1016/0006-8993(93)90309-B · DOI · Paper page
- 10.2165/00003088-197601030-00004 · DOI · Paper page
- 10.1016/j.neuron.2011.02.015 · DOI · Paper page
- 10.1016/j.alcohol.2006.12.002 · DOI
- 10.1007/BF01940430 · DOI
- 10.1016/j.pbb.2009.02.008 · DOI · Paper page
- 10.1111/j.1530-0277.2010.01148.x · DOI
- 10.1016/0006-8993(83)91146-0 · DOI
- 10.1093/alcalc/35.6.587 · DOI · Paper page
- 10.1016/S0893-133X(02)00302-0 · DOI · Paper page
- 10.1126/science.2882604 · DOI · Paper page
- 10.1016/j.biopsych.2012.01.027 · DOI
- 10.1016/j.conb.2004.05.005 · DOI · Paper page
- Cowan A, 1988, J Pharm Exp Therap, 246, 950
- 10.1001/archpsyc.1997.01830240090013 · DOI · Paper page
- 10.1111/j.1369-1600.2011.00326.x · DOI · Paper page
- 10.1016/j.neuroimage.2003.07.025 · DOI
- 10.1111/j.1530-0277.1999.tb04099.x · doi:10.1111/j.1530-0277.1999.tb04099.x · Paper page
- 10.1111/j.1530-0277.1996.tb01679.x · DOI · Paper page
- 10.1016/j.paid.2003.11.001 · DOI
- 10.1159/000126428 · DOI · Paper page
- Devine DP, 1993, J Pharmacol Exp Ther, 266, 1236
- 10.1523/JNEUROSCI.14-04-01978.1994 · DOI · Paper page
- Di Chiara G, 1998, J Pharmacol Exp Ther, 244, 1067
- 10.1016/0165-6147(92)90062-B · DOI · Paper page
- 10.1002/j.1552-4604.1987.tb02191.x · DOI · Paper page
- 10.1038/clpt.1986.9 · DOI · Paper page
- 10.1038/sj.npp.1300101 · DOI
- 10.1111/j.1360-0443.2008.02203.x · DOI · Paper page
- 10.1016/0143-4179(85)90005-8 · doi:10.1016/0143-4179(85)90005-8
- 10.1007/BF00176481 · DOI
- Emmerson PJ, 1994, J Pharmacol Exp Ther, 271, 1630
- 10.1111/j.1369-1600.2011.00378.x · DOI
- 10.1016/j.biopsycho.2011.06.007 · DOI
- 10.1016/S0009-9236(97)90178-8 · doi:10.1016/s0009-9236(97)90178-8
- 10.1038/clpt.1991.32 · DOI
- 10.1038/clpt.1986.220 · DOI · Paper page
- 10.1016/0014-2999(90)90588-W · DOI
- Gianoulakis C, 1993, J Psychiat Neurosci, 18, 148
- 10.1016/0024-3205(87)90247-5 · DOI
- Gonzales R, 1997, Alcohol Health Res World, 21, 120
- 10.1523/JNEUROSCI.18-24-10663.1998 · DOI · Paper page
- 10.1016/0143-4179(85)90006-X · DOI
- 10.1016/j.euroneuro.2013.02.006 · DOI · Paper page
- 10.1016/j.pbb.2006.10.015 · DOI
- 10.1016/0166-2236(82)90037-6 · DOI · Paper page
- 10.1097/00004714-200106000-00006 · DOI · Paper page
- 10.1093/alcalc/agg005 · DOI · Paper page
- 10.1001/archpsyc.62.1.57 · DOI · Paper page
- 10.1007/s002130050169 · DOI · Paper page
- 10.1002/1096-9861(20000828)424:3<489::AID-CNE7>3.0.CO;2-O · DOI
- 10.1016/j.ejpain.2008.03.010 · DOI
- 10.1016/0091-3057(93)90527-Z · DOI
- 10.1111/j.1530-0277.1993.tb00810.x · DOI · Paper page
- 10.1038/sj.npp.1300790 · DOI
- Iovcheva M, 2007, Addict Biol, 1, 75
- 10.1016/0024-3205(82)90386-1 · DOI
- 10.1038/sj.npp.1300338 · DOI
- June HL, 1998, Alcohol Clin Exp Res, 22, 2174
- 10.1007/s002130051145 · DOI
- 10.1038/298245a0 · DOI · Paper page
- 10.1111/j.1530-0277.2011.01439.x · DOI · Paper page
- Kim S, 1997, J Nucl Med, 38, 1726
- 10.1016/S0006-8993(97)00988-8 · DOI · Paper page
- 10.1016/j.ejphar.2008.02.035 · DOI
- 10.1046/j.1360-0443.95.8s2.17.x · DOI · Paper page
- 10.1097/01.ALC.0000164361.62346.D6 · DOI · Paper page
- 10.1016/S0893-133X(99)00135-9 · DOI · Paper page
- Kranzler HR, 1998, Alcohol Clin Exp Res, 22, 1074
- Kreek MJ, 1999, J Pharmacol Exp Ther, 288, 260
- 10.1007/BF02246191 · DOI
- 10.1016/0091-3057(95)00080-G · DOI
- 10.1016/S0091-3057(97)00474-7 · DOI · Paper page
- 10.1007/s00213-008-1267-8 · DOI
- 10.1016/j.jsat.2008.07.001 · DOI
- 10.1073/pnas.76.11.5455 · DOI
- Lee MC, 1988, J Nucl Med, 29, 1207
- 10.1016/S0091-3057(97)00002-6 · doi:10.1016/s0091-3057(97)00002-6
- 10.1046/j.1360-0443.95.8s2.18.x · DOI · Paper page
- 10.1016/S0006-3223(00)00885-4 · DOI
- 10.1016/j.biopsych.2012.10.020 · DOI · Paper page
- 10.1111/j.1530-0277.2008.00690.x · DOI · Paper page
- 10.1016/0166-2236(95)93946-U · DOI · Paper page
- Mansour A, 1987, J Neurosci, 7, 2445
- 10.1016/0091-3057(83)90232-0 · DOI
- 10.1523/JNEUROSCI.23-31-09981.2003 · DOI · Paper page
- 10.1111/j.1530-0277.2006.00112.x · DOI · Paper page
- 10.1016/j.drugalcdep.2008.07.018 · DOI · Paper page
- Martin WR, 1976, J Pharm Exp Ther, 197, 517
- 10.1001/archpsyc.1973.01750360022003 · DOI · Paper page
- 10.1111/j.1530-0277.1994.tb00098.x · DOI · Paper page
- 10.1001/archpsyc.56.8.719 · DOI · Paper page
- 10.1073/pnas.90.21.9954 · DOI · Paper page
- 10.1038/377532a0 · DOI · Paper page
- Meyer MC, 1984, J Clin Psychiatry, 45, 15
- Michaelis EF, 1993, Alcohol Alcohol, S377
- Michel ME, 1985, Methods Find Exp Clin Pharmacol, 7, 175
- 10.1016/S0197-0186(99)00053-4 · DOI · Paper page
- 10.1038/sj.npp.1301226 · DOI
- 10.1016/0014-5793(94)80235-1 · DOI · Paper page
- Morgan CJ, 1989, Alcohol Alcohol, 24, 185
- 10.1007/BF00432213 · DOI · Paper page
- 10.1016/0197-0186(94)00140-P · DOI
- 10.1038/278423a0 · DOI · Paper page
- 10.1002/(SICI)1096-9861(19990419)406:4<503::AID-CNE7>3.0.CO;2-P · DOI · Paper page
- 10.1038/81570 · DOI · Paper page
- 10.1038/295202a0 · DOI · Paper page
- 10.1007/s11920-001-0042-x · DOI
- 10.1001/archpsyc.1992.01820110045007 · DOI · Paper page
- 10.1001/archpsyc.1992.01820110045007 · DOI · Paper page
- Oberlin BG, 2010, Alcohol Clin Exp Res, 34, 1363, 10.1111/j.1530-0277.2010.01220.x · DOI
- 10.1523/JNEUROSCI.21-23-j0002.2001 · DOI · Paper page
- 10.1371/journal.pone.0004410 · DOI · Paper page
- 10.1016/j.lfs.2010.02.013 · DOI
- 10.1016/j.physbeh.2004.02.008 · DOI · Paper page
- Overstreet DH, 1999, Alcohol Clin Exp Res, 23, 1761
- 10.1016/S0165-6147(98)01169-9 · DOI · Paper page
- 10.1016/S0306-4522(98)00251-6 · DOI · Paper page
- 10.1111/j.1600-0447.1992.tb03309.x · DOI · Paper page
- 10.1111/j.1530-0277.1997.tb03824.x · doi:10.1111/j.1530-0277.1997.tb03824.x
- Prescott CA, 1999, Alcohol Clin Exp Res, 23, 101
- 10.1016/0304-3940(92)90515-9 · DOI
- 10.1111/j.1530-0277.1998.tb03870.x · DOI
- 10.2174/187152710790966704 · DOI · Paper page
- 10.1016/0741-8329(91)90305-G · DOI
- Remmers AE, 1999, J Pharmacol Exp Ther, 288, 827
- 10.1016/1044-5765(92)90010-Y · DOI · Paper page
- Roberts AJ, 2001, Alcohol Clin Exp Res, 25, 1249
- Roberts AJ, 2000, J Pharmacol Exp Ther, 293, 1002
- 10.1016/0165-0173(93)90013-P · DOI · Paper page
- 10.1517/13543784.2010.500612 · DOI
- 10.1111/j.1530-0277.2000.tb04573.x · doi:10.1111/j.1530-0277.2000.tb04573.x · Paper page
- 10.1016/j.ejphar.2010.07.036 · DOI
- Rutten K, 2011, Drug Alcohol Depend, 114, 253
- 10.1016/0091-3057(85)90491-5 · DOI · Paper page
- 10.1016/j.neulet.2004.11.025 · DOI
- 10.1016/0091-3057(83)90200-9 · DOI
- 10.1111/j.1530-0277.2001.tb02309.x · DOI
- Shippenberg TS, 2009, Neuropharmacol, 34, 247
- 10.1007/BF02244205 · DOI
- 10.1111/j.1749-6632.1992.tb25980.x · DOI
- 10.1073/pnas.92.15.7006 · DOI · Paper page
- 10.1073/pnas.89.6.2046 · DOI · Paper page
- 10.1097/00131746-200603000-00003 · DOI · Paper page
- 10.1007/s002210050545 · DOI · Paper page
- 10.1016/0014-2999(84)90374-1 · DOI
- 10.1111/j.1369-1600.2011.00323.x · DOI · Paper page
- 10.1046/j.1360-0443.95.8s2.3.x · DOI · Paper page
- 10.1038/clpt.1983.70 · DOI
- 10.1186/1471-2202-8-103 · DOI
- 10.1038/sj.bjp.0700971 · DOI · Paper page
- 10.1016/0024-3205(79)90170-X · DOI
- 10.3109/00952997509005661 · DOI
- 10.1093/alcalc/34.2.197 · DOI · Paper page
- 10.1001/archpsyc.1997.01830200071010 · DOI · Paper page
- 10.1038/npp.2013.129 · DOI
- 10.1096/fj.08-0702LTR · DOI
- 10.1111/j.1530-0277.2001.tb02327.x · doi:10.1111/j.1530-0277.2001.tb02327.x · Paper page
- 10.1016/S0893-133X(01)00294-9 · DOI · Paper page
- 10.1111/j.1369-1600.2011.00430.x · DOI
- 10.1093/alcalc/agn100 · DOI · Paper page
- 10.1111/adb.12073 · DOI
- 10.1007/s00213-010-1825-8 · DOI · Paper page
- 10.1111/j.1530-0277.2011.01565.x · DOI · Paper page
- 10.1038/sj.npp.1301263 · DOI · Paper page
- 10.1192/bjp.bp.106.031120 · DOI · Paper page
- 10.1016/j.euroneuro.2009.06.007 · DOI
- World Health Organization, 2000, International Guide for Monitoring Alcohol Consumption and Related Harm
- 10.1016/j.neuroscience.2008.01.040 · DOI
- 10.1111/j.1530-0277.2007.00405.x · DOI
- 10.1038/sj.mp.4001882 · DOI · Paper page
- 10.1111/j.1526-4637.2011.01279.x · DOI
- 10.1038/386499a0 · DOI · Paper page
- 10.1074/jbc.270.39.22772 · DOI
- 10.1016/0024-3205(94)00507-O · DOI
Cited by
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390
“Typically, MOR, KOR and DORs are coupled to Gi-proteins, reducing (in most cases) net neuronal excitability and reducing neurotransmitter release upon activation [reviewed in (Nutt, 2014)].”
BackgroundDrug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
Treatment-refractory substance use disorder: focus on alcohol, opioids, and cocaine
Soyka, M., & Mutschler, J. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.003 · Cited by 49
Barsuglia, J. P., Polanco, M., Palmer, R., Malcolm, B. J., Kelmendi, B., & Calvey, T. (2018) · Progress in Brain Research · doi:10.1016/bs.pbr.2018.08.002 · Cited by 38
Metadata
- Authors
- Nutt, D. J.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2013-09-18
- Volume
- 28
- Issue
- 1
- Pages
- 8-22
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W1981141287
- Cited by
- 85
- References
- 20
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of the opioid system in alcohol dependence. https://app.cochat.ai/papers/10.1177/0269881113504017
- The paper
- Nutt, D. J. (2014). The role of the opioid system in alcohol dependence. Journal of Psychopharmacology. https://doi.org/10.1177/0269881113504017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.